Perkin-Elmer hooks up polymerase chain reaction (PCR) and sequencing for diagnostics
This article was originally published in Clinica
Executive Summary
Swiss pharmaceutical company Roche has granted Perkin-Elmer a licence to develop diagnostic systems using PCR. The agreement allows Perkin-Elmer to combine PCR with its electrophoresis-based DNA analysis systems. This is an extension of a previous licence which allows Perkin-Elmer's applied biosystems division to use PCR with its DNA analysis systems for research.